DE:2EB0 / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock) - Net Long/Short Value
| Właściciel | Wartość kapitału (1000$) |
Wartość opcji call (1000$) |
Wartość opcji put (1000$) |
Długa/krótka netto (1000$) |
|---|---|---|---|---|
| Woodline Partners LP | ||||
| UBS Group AG | ||||
| Rhumbline Advisers | ||||
| Citadel Advisors Llc | ||||
| Centiva Capital, LP | ||||
| Dauntless Investment Group, LLC | ||||
| Morgan Stanley | ||||
| GAMMA Investing LLC | ||||
| Velan Capital Investment Management LP | ||||
| Huntington National Bank | ||||
| Birchview Capital, LP | ||||
| AIGH Capital Management LLC | ||||
| SBI Securities Co., Ltd. | ||||
| Millennium Management Llc | ||||
| Boothbay Fund Management, Llc | ||||
| Ikarian Capital, LLC | ||||
| Standard Life Aberdeen plc | ||||
| Soleus Capital Management, L.P. | ||||
| Stonepine Capital Management, LLC | ||||
| SummitTX Capital, L.P. | ||||
| Royal Bank Of Canada |